[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100636147":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":11,"locations":20,"responsibleParty":42,"collaborators":11,"id":44,"slug":11,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":11,"eligibilityCriteria":49,"healthyVolunteers":50,"sex":51,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":11,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":11,"overallStatus":23,"whyStopped":11,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Kimberly-Clark Corporation","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Test Tampon","EXPERIMENTAL",null,[13],"Device: Tampon A",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DEVICE","Tampon A","Commercially available tampons in regular, super, and super plus absorbencies",[9],[21],{"facility":22,"status":23,"city":24,"state":25,"zip":26,"country":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Princeton Consumer Research","RECRUITING","St. Petersburg","Florida","33702","United States",{"type":29,"coordinates":30},"Point",[31,32],-82.67927,27.77086,{"lat":32,"lon":31},[35,40],{"name":36,"role":37,"phone":38,"phoneExt":11,"email":39},"Christine Maraghy","CONTACT","727-576-7300","info@princetonconsumer.com",{"name":36,"role":41,"phone":11,"phoneExt":11,"email":11},"PRINCIPAL_INVESTIGATOR",{"type":43,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100636147",false,"NCT07561905","Tampon Safety-in-Use Study","An Open-Label Applicator Tampon Safety-in-Use Study","Key Inclusion Criteria:\n\n* Willing and able to read and provide written informed consent.\n* Female in good general health, age 18-49 (inclusive).\n* History of regular menstrual cycles during the previous 3months lasting approximately 21-35 days, including at least 4 days of menstruation, and expecting to menstruate during the study period.\n* History of use of applicator tampons within the past 12 months without discomfort.\n* Tracks menstruation and be able to confidently predict onset of menstruation\n* Normally use at least 6 tampons for protection during menstruation.\n* Normally uses regular, super, and\u002For super plus absorbency tampons for menstrual protection.\n* Agrees to the conduct of all study procedures, including gynecological exams and agrees to follow all study instructions and return for scheduled appointments.\n* Has used an acceptable form of birth control for at least one month prior to enrollment and for the duration of the study.\n\nKey Exclusion Criteria:\n\n* Pregnant, lactating or is trying to become pregnant.\n* Less than six (6) weeks post-partum.\n* Has a menstrual abnormality (such as oligomenorrhea or amenorrhea).\n* Has a known allergy or sensitivity to components of the investigational products\n* Any other medical condition or history, as determined by the Investigator that could compromise the study results or subject safety.",true,"FEMALE","18 Years","49 Years",{"count":55,"type":56},60,"ESTIMATED","INTERVENTIONAL",[59],"NA","The goal of this clinical trial is to confirm the safety of a tampon in healthy female volunteers. Participants will use the study tampons as they normally would for one menstrual cycle. Gynecological exams will be conducted before and after the menstrual cycle.",[62],"Menstruation","2026-05-19",{"date":65,"type":66},"2026-05-22","ACTUAL",{"date":68,"type":66},"2026-05-12",{"date":70,"type":56},"2026-06-08",{"name":5,"class":6},1]